Cargando…

Crystallization of a nonreplicating rotavirus vaccine candidate

Nonreplicating rotavirus vaccine (NRRV) candidates are being developed with the aim of serving the needs of developing countries. A significant proportion of the cost of manufacturing such vaccines is the purification in multiple chromatography steps. Crystallization has the potential to reduce puri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Moo Sun, Kaur, Kawaljit, Sawant, Nishant, Joshi, Sangeeta B., Volkin, David B., Braatz, Richard D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	COMMUNICATION TO THE EDITOR
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248096/ https://www.ncbi.nlm.nih.gov/pubmed/33527346 http://dx.doi.org/10.1002/bit.27699

Ejemplares similares

Holistic process development to mitigate proteolysis of a subunit rotavirus vaccine candidate produced in Pichia pastoris by means of an acid pH pulse during fed‐batch fermentation
por: Velez‐Suberbie, M. Lourdes, et al.
Publicado: (2020)

Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
por: Sawant, Nishant, et al.
Publicado: (2021)

Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine
por: Kaur, Kawaljit, et al.
Publicado: (2021)

Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency
por: McAdams, David, et al.
Publicado: (2022)

Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2019)

Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus
por: Dalvie, Neil C., et al.
Publicado: (2021)

Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
por: Whitaker, Neal, et al.
Publicado: (2019)

Availability and Accessibility of Live Nonreplicating Smallpox/Mpox Vaccine
por: Kahn, Peter A., et al.
Publicado: (2023)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery
por: Kumar, Prashant, et al.
Publicado: (2021)

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
por: Mudrick, Haley E., et al.
Publicado: (2022)

Eagle Effect in Nonreplicating Persister Mycobacteria
por: Wu, Mu-Lu, et al.
Publicado: (2015)

Nonreplicative functions of the origin recognition complex
por: Popova, Varvara V., et al.
Publicado: (2018)

Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Existence and significance of viral nonreplicative RNA recombination
por: Agol, Vadim I.
Publicado: (2023)

Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis
por: Rakesh,, et al.
Publicado: (2014)

Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis
por: Gold, Ben, et al.
Publicado: (2016)

Antibiotic Killing of Diversely Generated Populations of Nonreplicating Bacteria
por: McCall, Ingrid C., et al.
Publicado: (2019)

Plasmodium berghei sporozoites in nonreplicative vacuole are eliminated by a PI3P‐mediated autophagy‐independent pathway
por: Bindschedler, Annina, et al.
Publicado: (2020)

Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
por: Baz, Mariana, et al.
Publicado: (2015)

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine
por: Hamidi, Ahd, et al.
Publicado: (2021)

A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system
por: Lee, Shwu-Maan, et al.
Publicado: (2020)

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
por: Kumar, Prashant, et al.
Publicado: (2023)

Serum neopterin levels in patients with replicative and nonreplicative HBV carriers
por: Kaleli, Ilknur, et al.
Publicado: (2006)

Rotavirus Vaccine Demand in Pakistan
por: HUSSAIN, Aamir
Publicado: (2016)

Droplet-Based Evaporative System for the Estimation of Protein Crystallization Kinetics
por: Hong, Moo Sun, et al.
Publicado: (2021)

Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
por: Tessarollo, Nayara Gusmão, et al.
Publicado: (2021)

The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
por: Lee, Shwu-Maan, et al.
Publicado: (2019)

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
por: Kumar, Prashant, et al.
Publicado: (2022)

Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine
por: Kumru, Ozan S., et al.
Publicado: (2019)

Rotaviruses and Rotavirus Vaccines
por: Donato, Celeste M., et al.
Publicado: (2021)

Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery
por: Wang, Y, et al.
Publicado: (2005)

Role of Alanine Dehydrogenase of Mycobacterium tuberculosis during Recovery from Hypoxic Nonreplicating Persistence
por: Giffin, Michelle M., et al.
Publicado: (2016)

Ribosome Rescue Inhibitors Kill Actively Growing and Nonreplicating Persister Mycobacterium tuberculosis Cells
por: Alumasa, John N., et al.
Publicado: (2017)

ROTAVIRUS INFECTIONS OF APES
por: Ashley, C.R., et al.
Publicado: (1978)

Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

Ovine rotavirus strain LLR-85-based bovine rotavirus candidate vaccines: Construction, characterization and immunogenicity evaluation
por: Chang, Ji-Tao, et al.
Publicado: (2010)

Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis
por: Gold, Ben, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d5g5ofl4jgck8ohhd6lbnhjvna